IMAC Holdings, Inc. has launched Ignite Proteomics LLC, a new subsidiary focused on enhancing cancer treatment personalization through protein-level analysis. This initiative aims to improve the ...

SAMBAI, a team funded through the Cancer Grand Challenges initiative, reported that Akoya Biosciences’ PhenoCycler ®-Fusion system will be the foundational spatial proteomics technology used to ...

When Matthew Padula was diagnosed with a rare bladder cancer in 2020, he knew there was a challenging road ahead of him. As a researcher at the University of Technology Sydney, his first instinct was ...

PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer, today announced ...

Nautilus Biotechnology has announced Baylor College of Medicine as the first customer of the early access program for its proteomics technology. As part of the program, Baylor will use Nautilus’ ...

Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an ...

OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...

Candidate molecular alterations associated with potential resistance in KRAS G12D gastrointestinal cancers. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...

Understanding how the nervous system influences cancer growth, spread, and immune responses is a burgeoning field in cancer ...